Gyre Therapeutics, Inc.
GYRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001124105
No open-market purchases or sales by Gyre Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Gyre Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- −8 vs. Q4 2021
- Shares held
- 9.68M
- −5.37M (−35.7%) vs. Q4 2021
- Total value
- $6.39M
- −$7.36M (−53.6%) vs. Q4 2021
- New holders
- 2
- 9 more added
- Sold out
- 10
- 17 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GYRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 59 | $57.1M |
| Q1 2026 | 56 | $23.8M |
| Q4 2025 | 44 | $23.6M |
| Q3 2025 | 48 | $23.1M |
| Q2 2025 | 48 | $25.1M |
| Q1 2025 | 46 | $20.1M |
| Q4 2024 | 41 | $21.6M |
| Q3 2024 | 37 | $20.2M |
| Q2 2024 | 30 | $15.0M |
| Q1 2024 | 21 | $14.3M |
| Q4 2023 | 16 | $15.6M |
| Q3 2023 | 32 | $1.04M |
| Q2 2023 | 29 | $796.3K |
| Q1 2023 | 40 | $707.6K |
| Q4 2022 | 35 | $2.63M |
| Q3 2022 | 35 | $3.90M |
| Q2 2022 | 41 | $14.2M |
| Q1 2022 | 43 | $6.39M |
| Q4 2021 | 51 | $13.7M |
| Q3 2021 | 66 | $75.7M |
| Q2 2021 | 69 | $87.7M |
| Q1 2021 | 89 | $113.0M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Gyre Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 2,420,789 | $1.60M | 0.11% | −340,871−12.3% | Reduced |
| Vanguard Group Inc | 1,393,512 | $920.0K | 0.00% | 00.0% | Unchanged |
| Sabby Management, LLC | 1,320,000 | $871.0K | 0.37% | +181,666+16.0% | Added |
| Renaissance Technologies LLC | 1,169,862 | $772.0K | 0.00% | −602,046−34.0% | Reduced |
| Millennium Management LLC | 637,799 | $421.0K | 0.00% | −271,439−29.9% | Reduced |
| Ikarian Capital, LLC | 476,625 | $314.0K | 0.10% | +22,279+4.9% | Added |
| Geode Capital Management, LLC | 299,201 | $197.0K | 0.00% | +12,616+4.4% | Added |
| BlackRock Inc. | 253,585 | $168.0K | 0.00% | −3,699−1.4% | Reduced |
| Bank of New York Mellon Corp | 216,807 | $143.0K | 0.00% | +141,498+187.9% | Added |
| RBF Capital, LLC | 132,396 | $87.0K | 0.01% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 117,312 | $77.0K | 0.00% | −123,299−51.2% | Reduced |
| Acadian Asset Management LLC | 118,789 | $77.0K | 0.00% | −113,611−48.9% | Reduced |
| Kynam Capital Management, LP | 106,089 | $70.0K | 0.02% | −4,902−4.4% | Reduced |
| CSS LLC | 88,656 | $59.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 83,688 | $55.0K | 0.00% | −18,468−18.1% | Reduced |
| Essex Woodlands Management, Inc. | 78,622 | $52.0K | 0.01% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 77,127 | $51.0K | 0.00% | −415,574−84.3% | Reduced |
| State Street Corp | 72,599 | $48.0K | 0.00% | 00.0% | Unchanged |
| Johnson & Johnson | 66,951 | $44.0K | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 62,725 | $41.0K | 0.00% | −451,503−87.8% | Reduced |
| Two Sigma Investments, LP | 62,729 | $41.0K | 0.00% | −245,823−79.7% | Reduced |
| D. E. Shaw & Co., Inc. | 62,368 | $41.0K | 0.00% | −77,818−55.5% | Reduced |
| Boothbay Fund Management, LLC | 45,915 | $30.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 44,737 | $30.0K | 0.00% | +3,809+9.3% | Added |
| Stephens Inc | 37,210 | $25.0K | 0.00% | +8,025+27.5% | Added |
| HSBC Holdings PLC | 32,528 | $22.0K | 0.00% | 00.0% | Unchanged |
| Raymond James & Associates | 32,500 | $21.0K | 0.00% | −300−0.9% | Reduced |
| Barclays PLC | 30,102 | $20.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 27,000 | $18.0K | 0.00% | −155,100−85.2% | Reduced |
| Bank of America Corp | 24,713 | $16.0K | 0.00% | −376−1.5% | Reduced |
| Gyon Technologies Capital Management, LP | 23,421 | $15.0K | 0.01% | −133,129−85.0% | Reduced |
| Black Diamond Financial, LLC | 18,000 | $12.0K | 0.00% | 00.0% | Unchanged |
| Colorado Capital Management, Inc. | 13,712 | $9.00K | 0.01% | 00.0% | Unchanged |
| Geneos Wealth Management Inc. | 11,000 | $7.00K | 0.00% | +2,786+33.9% | Added |
| Commonwealth Equity Services, LLC | 10,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 5,500 | $3.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 3,082 | $2.00K | 0.00% | +3,033+6,189.8% | Added |
| Tower Research Capital LLC (TRC) | 3,175 | $2.00K | 0.00% | +3,175 | New |
| Steward Partners Investment Advisory, LLC | 1,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 368 | $243 | 0.00% | −96−20.7% | Reduced |
| American Portfolios Advisors | 215 | $142 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 480 | $0 | 0.00% | +1+0.2% | Added |
| Blue Bell Private Wealth Management, LLC | 30 | $0 | 0.00% | +30 | New |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −1,729,402−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −512,643−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −356,804−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −67,605−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −47,441−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −31,516−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −17,379−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −16,076−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −5,205−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −2,294−100.0% | Sold out |